Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in ALS
NCT01786603Phase 2Completed
- Start
- Nov 2013
- Primary completion
- Jul 2016
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of rasagiline in amyotrophic lateral sclerosis (ALS). Started Nov 2013; status: completed.
02
Drugs
rasagiline
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01786603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786603.